Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Reexamination Certificate
2009-12-02
2010-10-19
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
C424S094100, C424S185100, C530S350000, C435S183000
Reexamination Certificate
active
07815919
ABSTRACT:
This document relates to methods and materials involved in fungus-induced inflammation and eosinophil degranulation. For example, isolated nucleic acids encoding fungal polypeptides, fungal polypeptides, methods for assessing fungus-induced inflammation, methods for assessing eosinophil degranulation, and methods for identifying inhibitors of fungus-induced inflammation and/or eosinophil degranulation are provided.
REFERENCES:
Minetoki et al (Biosci. Biotechnol. Biochem. 1995. 59: 1516-1521).
Kita Hirohito
Lawrence Christopher B.
Ponikau Jens
Fish & Richardson P.C.
Graser Jennifer E
Mayo Foundation for Medical Education and Research
Virginia Tech Intellectual Properties Inc.
LandOfFree
Fungus-induced inflammation and eosinophil degranulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fungus-induced inflammation and eosinophil degranulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fungus-induced inflammation and eosinophil degranulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4185862